| Aetna | Golimumab (Simponi and Simponi Aria) | 2026-07-31 |
| Aetna | Hip Preservation Surgery | 2026-07-31 |
| Medicare Noridian | Billing and Coding: MolDX: Molecular Testing for Solid Organ Allograft Rejection (60152) | 2026-07-31 |
| Medicare Noridian | Billing and Coding: MolDX: Molecular Testing for Solid Organ Allograft Rejection (60155) | 2026-07-31 |
| Medicare Wellpoint NGS | Billing and Coding: Bevacizumab and biosimilars (52370) | 2026-07-31 |
| Medicare WPS | Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers (58468) | 2026-07-31 |
| Medicare WPS | Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer (58756) | 2026-07-31 |
| Medicare WPS | Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (58761) | 2026-07-31 |
| Aetna | Coronary Artery Brachytherapy and Other Adjuncts to Coronary Interventions | 2026-07-30 |
| Aetna | Kidney Transplantation | 2026-07-30 |